Maltol

CAS No. 118-71-8

Maltol( Larixinic acid | Palatone | Veltol )

Catalog No. M20239 CAS No. 118-71-8

Maltol is a naturally occurring organic compound that is flavour enhancer and flavouring agent. Maltol also is a potent antioxidative agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 38 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Maltol
  • Note
    Research use only, not for human use.
  • Brief Description
    Maltol is a naturally occurring organic compound that is flavour enhancer and flavouring agent. Maltol also is a potent antioxidative agent.
  • Description
    Maltol is a naturally occurring organic compound that is flavour enhancer and flavouring agent. Maltol also is a potent antioxidative agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Larixinic acid | Palatone | Veltol
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    118-71-8
  • Formula Weight
    126.11
  • Molecular Formula
    C6H6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mg/mL;Water: 10 mg/mL (79.29 mM);Ethanol: 35 mg/mL
  • SMILES
    Cc1occc(=O)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hong S et al. Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress. Mol Vis. 2014 Oct 17;20:1456-62.
molnova catalog
related products
  • Maltol

    Maltol is a naturally occurring organic compound that is flavour enhancer and flavouring agent. Maltol also is a potent antioxidative agent.

  • Prifelone

    Prifelone (R 830) is a non-steroidal anti-inflammatory compound with antioxidant activity.

  • BMY-21502

    BMY-21502 is a potential cognitive enhancer that shows anti-hypoxia effects in the KCN-hypoxia model, delays the decay of hippocampal synaptic enhancement in vitro, and can be used to study Alzheimer's disease.